<?xml version="1.0" encoding="UTF-8"?>
<Label drug="crinone" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Assisted Reproductive Technology

  In a study of 61 women with ovarian failure undergoing a donor oocyte transfer procedure receiving Crinone  (r)  8% twice daily, treatment-emergent adverse events occurring in 5% or more of the women are shown in Table 3.



 TABLE 3 Treatment-Emergent Adverse Events in &gt;=5% of Women Receiving Crinone(r) 8% Twice Daily Study COL1620-007US (n=61) 
 Body as a Whole                                                
   Bloating                                                                       7%                      
   Cramps NOS                                                                    15%                      
   Pain                                                                           8%                      
 Central and Peripheral Nervous System                          
   Dizziness                                                                      5%                      
   Headache                                                                      13%                      
 Gastro-Intestinal System                                       
   Nausea                                                                         7%                      
 Reproductive, Female                                           
   Breast Pain                                                                   13%                      
   Moniliasis Genital                                                             5%                      
   Vaginal Discharge                                                              7%                      
 Skin and Appendages                                            
   Pruritus Genital                                                               5%                      
        In a second clinical study of 139 women using Crinone  (r)  8% once daily for luteal phase support while undergoing an in vitro fertilization procedure, treatment-emergent adverse events reported in &gt;=5% of the women are shown in Table 4.
 

 TABLE 4 Treatment-Emergent Adverse Events in &gt;=5% of Women Receiving Crinone(r) 8% Once Daily Study COL1620-F01 (n=139) 
 Body as a Whole                                                
   Abdominal Pain                                                                12%                      
   Perineal Pain Female                                                          17%                      
 Central and Peripheral Nervous System                          
   Headache                                                                      17%                      
 Gastro-Intestinal System                                       
   Constipation                                                                  27%                      
   Diarrhea                                                                       8%                      
   Nausea                                                                        22%                      
   Vomiting                                                                       5%                      
 Musculo-Skeletal System                                        
   Arthralgia                                                                     8%                      
 Psychiatric                                                    
   Depression                                                                    11%                      
   Libido Decreased                                                              10%                      
   Nervousness                                                                   16%                      
   Somnolence                                                                    27%                      
 Reproductive, Female                                           
   Breast Enlargement                                                            40%                      
   Dyspareunia                                                                    6%                      
 Urinary System                                                 
   Nocturia                                                                      13%                      
          Secondary Amenorrhea
   In three studies, 127 women with secondary amenorrhea received estrogen replacement therapy and Crinone  (r)  4% or 8% every other day for six doses. Treatment emergent adverse events during estrogen and Crinone  (r)  treatment that occurred in 5% or more of women are shown in Table 5.



 TABLE 5 Treatment-Emergent Adverse Events in &gt;=5% of Women Receiving Estrogen Treatment and Crinone(r) Every Other Day Studies COL1620-004US, COL1620-005US, COL1620-009US 
                                            Estrogen + Crinone(r) 4%n=62    Estrogen + Crinone(r) 8%n=65    
  
 Body as a Whole                            
   Abdominal Pain                                      3 (5%)                          6 (9%)               
   Appetite Increased                                  3 (5%)                          5 (8%)               
   Bloating                                           8 (13%)                         8 (12%)               
   Cramps NOS                                         12 (19%)                        17 (26%)              
   Fatigue                                            13 (21%)                        14 (22%)              
 Central and Peripheral Nervous System      
   Headache                                           12 (19%)                        10 (15%)              
 Gastro-Intestinal System                   
   Nausea                                              5 (8%)                          4 (6%)               
 Musculo-Skeletal System                    
   Back Pain                                           5 (8%)                          2 (3%)               
   Myalgia                                             5(8%)                           0(0%)                
 Psychiatric                                
   Depression                                         12 (19%)                        10 (15%)              
 Emotional Lability                                   14 (23%)                        14 (22%)              
   Sleep Disorder                                     11 (18%)                        12 (18%)              
 Reproductive, Female                       
   Vaginal Discharge                                  7 (11%)                          2 (3%)               
 Resistance Mechanism                       
   Upper Respiratory Tract Infection                   3 (5%)                          5 (8%)               
 Skin and Appendages                        
   Pruitis genital                                     1 (2%)                          4 (6%)               
         Additional adverse events reported in women at a frequency &lt;5% in Crinone  (r)  ART and secondary amenorrhea studies and not listed in the tables above include:
 

 Autonomic Nervous System-mouth dry, sweating increased



 Body as a Whole-abnormal crying, allergic reaction, allergy, appetite decreased, asthenia, edema, face edema, fever, hot flushes, influenza-like symptoms, water retention, xerophthalmia



 Cardiovascular, General-syncope



 Central and Peripheral Nervous System-migraine, tremor



 Gastro-Intestinal-dyspepsia, eructation, flatulence, gastritis, toothache



 Metabolic and Nutritional-thirst



 Musculo-Skeletal System-cramps legs, leg pain, skeletal pain



 Neoplasm-benign cyst



 Platelet, Bleeding &amp; Clotting-purpura



 Psychiatric-aggressive reactions, forgetfulness, insomnia



 Red Blood Cell-anemia



 Reproductive, Female-dysmenorrhea, premenstrual tension, vaginal dryness



 Resistance Mechanism-infection, pharyngitis, sinusitis, urinary tract infection



 Respiratory System-asthma, dyspnea, hyperventilation, rhinitis



 Skin and Appendages-acne, pruritis, rash, seborrhea, skin discoloration, skin disorder, urticaria



 Urinary System-cystitis, dysuria, micturition frequency



 Vision Disorders-conjunctivitis
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
